Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV2)”

Showing 20 of 0 results

Not applicableStudy completedNCT04386044
What this trial is testing

Investigating the Role of Vitamin D in the Morbidity of COVID-19 Patients

Who this might be right for
COVID-19Vitamin D Deficiency
Tameside General Hospital 986
Not applicableUnknownNCT04460599
What this trial is testing

Neurological Features During COVID19

Who this might be right for
Encephalitis
Centre d'Investigation Clinique et Technologique 805 30
Not applicableStudy completedNCT05901337
What this trial is testing

Cupping Therapy on Immune System in Post Covid -19

Who this might be right for
Covid-19 Patients
Cairo University 76
Not applicableStudy completedNCT05381675
What this trial is testing

Short Term Results of Tele-Rehabilitation

Who this might be right for
COVID-19Dyspnea
Harran University 60
Not applicableWithdrawnNCT04362267
What this trial is testing

Longitudinal Study of Covid-19 Infection Among HCW in a French University Hospital

Who this might be right for
Sars-CoV2
University Hospital, Lille
Large-scale testing (Phase 3)Study completedNCT04602000
What this trial is testing

Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 Infection

Who this might be right for
SARS-CoV-2 Infection
Celltrion 1,642
Post-approval studies (Phase 4)UnknownNCT04389801
What this trial is testing

Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection

Who this might be right for
Covid 19
Hesham Al-Inany 200
Not applicableUnknownNCT05000229
What this trial is testing

Residual Symptoms After Coronavirus Disease (COVID-19) in Lithuanian Population

Who this might be right for
Post-Covid Syndrome
Lithuanian University of Health Sciences 5,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT04488081
What this trial is testing

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Who this might be right for
COVID-19
QuantumLeap Healthcare Collaborative 1,500
Not applicableStudy completedNCT04506528
What this trial is testing

COVID EHR COHORT at the University of Wisconsin

Who this might be right for
COVID-19CancerNicotine Dependence+3 more
University of Wisconsin, Madison 1,634,381
Testing effectiveness (Phase 2)Study completedNCT04364737
What this trial is testing

CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients

Who this might be right for
COVID-19CoronavirusCoronavirus Infection
NYU Langone Health 941
Large-scale testing (Phase 3)Ended earlyNCT04435795
What this trial is testing

Inhaled Ciclesonide for Outpatients With COVID19

Who this might be right for
COVID 19
McGill University Health Centre/Research Institute of the McGill University Health Centre 215
Testing effectiveness (Phase 2)Study completedNCT04889209
What this trial is testing

Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 867
Not applicableUnknownNCT05172167
What this trial is testing

Prospective Evaluation of SARS-CoV-2 Antibodies Levels in a Vaccinated Population of Valle de Aburra

Who this might be right for
COVID-19
Universidad de Antioquia 200
Testing effectiveness (Phase 2)Study completedNCT04869592
What this trial is testing

A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19

Who this might be right for
COVID-19
National Vaccine and Serum Institute, China 3,100
Very early researchWithdrawnNCT04528771
What this trial is testing

S-Nitrosylation Therapy of COVID-19

Who this might be right for
SARS-CoV2 InfectionCovid19
James Reynolds
Testing effectiveness (Phase 2)Study completedNCT06676709
What this trial is testing

Effect of IMMUNEPOTENT-CRP on Serum Pro-Inflammatory Cytokines in Mild to Moderate COVID-19

Who this might be right for
COVID-19SARS-CoV2 Infection
Universidad Autonoma de Nuevo Leon 80
Testing effectiveness (Phase 2)Study completedNCT05567952
What this trial is testing

Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir

Who this might be right for
COVID-19
Pfizer 436
Post-approval studies (Phase 4)Study completedNCT04869358
What this trial is testing

Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 34
Not applicableStudy completedNCT07126392
What this trial is testing

You and Me Healthy: Test to Treat

Who this might be right for
COVID - 19
Duke University 913
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation